Help us make childhood cancer universally survivable.

By giving monthly, you directly support our continued research into discovering effective and less toxic treatments for childhood cancer.

Support Our Lab

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

I want to dedicate this donation to someone

In honor of... Details

Donation Total: $25.00 One Time

{amount} donation plus {fee_amount} to help cover fees.

Our team of scientists and engineers are on a mission...

We are a nonprofit biotech lab on a mission to make childhood cancer universally survivable. Every year, the FDA approves on average 12 drugs to treat adult cancer, but has only approved 8 drugs to treat childhood cancer since 1978. 

Learn More About Our Research

giving back childhood for

#GIVINGBACKCHILDHOOD

Latest News

Vince Lombardi Cancer Foundation Awards $160,000 Grant to Children’s Cancer Therapy Development Institute for Innovative Cancer Research

cc-TDI July 1, 2020

We would need to master nuclear fusion to reach the stars, but with an incredible grant of $160,000 ($320,000 over two years) from The Vince Lombardi Cancer Foundation’s forward-thinking Starr Children’s Fund, cc-TDI can explore the dynamic nature of fusion oncogenes. Fusion oncogenes are aberrations which are among the most powerful biomarkers and potential drug targets in translational cancer biology and represent a promising area for research into new cancer treatments for children. The Vince Lombardi Cancer Foundation (VLCF) board of directors and medical advisory board thoroughly reviewed grant requests from 18 top ranking organizations

Read More »
View All Blog Posts

In the Press

Beaverton lab identifies drug that turns off key gene in deadly childhood muscle cancer

By Elizabeth Hayes - Portland Business Journal
The Children's Cancer Therapy Development Institute is studying how a breast cancer drug candidate could impact children with an aggressive tumor in the soft muscle.
Read Article >

Scientists And Parents Band Together To Research Cures For Rare Childhood Cancer

By Esther Landhuis - NPR
Small patient numbers mean there's less motivation to allocate resources to study the diseases and develop potential drugs. Dozens of childhood cancers fall in this category, some so rare that few pediatric oncologists hear about them.
Read Article >

Scientists Tackle Lethal Childhood Brain Cancer

By Esther Landhuis - Scientific American
In precision medicine era, legacy gifts of patient brain tissue reveal disease mechanisms and new therapeutic approaches.
Read Article >

Beaverton's Children's Cancer Therapy Development Institute tackles deadliest child cancers

By Eric Apalategui - Beaverton Valley Times
Beyond an unmarked door into what looks like a shabby old warehouse in Old Town Beaverton, white-coated scientists are working to find ways to treat cancers that kill almost every child they afflict.
Read Article >

Current Research Projects

Patient-specific CSF testing system for medulloblastoma metastasis
We propose a pilot study to (1) design a computational model of patient-specific flow conditions in the vicinity of a brain tumor leptomeningeal metastasis, and (2) to experimentally test whether drug exposures under those flow conditions would be effective against medulloblastoma tumor cells that represent the biology of the patient’s tumor.
Learn More »
Marizomib in Medulloblastoma
The goal of this preclinical study is to validate marizomib as a treatment for medulloblastoma.
Learn More »
CureFast: Creating a Legacy by Accelerating Childhood Cancer Research
One in 5 children with cancer will not survive. We propose to address gaps in basic and translational research by improving model systems for pediatric diseases. To this end, we have developed a Legacy Gift (research autopsy) program called the Cancer Registry for Familial and Sporadic Tumors (CUREfast)
Learn More »
Clear Cell Sarcoma BigData – Drug Discovery
Clear Cell Sarcoma (CCS) is a very rare soft tissue of children and adults. The underlying clinical problem is that only surgery is curative: chemotherapy and radiation are ineffective. Relapse with metastases results in a significant unmet clinical need because surgery is not possible and effective targeted therapies have not yet been developed.
Learn More »
Previous
Next

A dedicated research team

Our research team is exploring and testing state-of-the-art treatment options for the most urgent issues facing children with cancer. 

Working in our own freestanding research institution allows us to act swiftly and nimbly to achieve results—bringing cost control, speed, purpose, and focus to translate effective treatments into the clinic. To get there, we perform basic science and translational research in our industrial modern lab site (a paint factory remodeled by Nike as an off-site creative space), adjacent to the Silicon Forest in Oregon.

Meet the Team

Navigation

Contact

Sign Up for Email or Text Updates

More Information

EIN: 46-5759569

cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)

 

Copyright 2019 – Children’s Cancer Therapy Development Institute

Close Menu